OzStar Therapeutics

            OzStar Therapeutics Pty Ltd © 2016                                                   Privacy Policy                                              

Health Centre Point is seeking patient with the following criteria to participate in a clinical trial. Please read the information below to find out if you are
eligible to participate in this clinical trial.

Trial registration number:     ACTRN12614000836639
Registry name:                     ANZCTR   
Universal Trial Number:        U1111-1158-9653
HREC Approval Number:      2014-10-542
Protocol:                               OZ-14-101
Protocol Version:                  01_V06 FINAL

In Search of Type 2 Diabetes Mellitus Patients

Have you been diagnosed with Type 2 Diabetes Mellitus within the past 1 to 10 years?

For the past 6 months, have you been taking sulphonylurea-only medication to treat your diabetes such as:

1)        Glibenclamide, also known as

2)        Gliclazide, also known as
                         Oziclide MR

3)        Glipizide, also known

4)        Glimepiride, also known as
                         Glimepiride Sandoz

The Health Centre Point is seeking volunteer Type 2 diabetes patients to participate in a clinical study, that will investigate if an investigational drug
(OZ101), taken in combination with your sulphonylurea-only medication, results in better control of blood glucose and improves the treatment of type 2

If you are between 25 to 65 years of age and your condition has been stable for the past 3 months then you may be eligible to participate in this study.

For more information please contact (02) 8883 0800
OR (02) 8883 0811 OR OR

For further information please also visit         

OZ-14-101 Trial Advertisement (Version 3)                                                                   29 October 2015
Patient Information